# Increased Mpro (SARS-CoV-2 CL3/nsp5) cleavage of ORF1a at site for mature NSP9 protein formation by 2.9x.
# MacDonald et al. (2021) https://doi.org/10.1101/2021.04.20.440716 [Preprint (BioRxiv); Now published at: https://doi.org/10.1021/acsinfecdis.1c00237]
N1A

# Increased Mpro (SARS-CoV-2 CL3/nsp5) cleavage of ORF1a at site for mature NSP9 protein formation by 2.1x.
# MacDonald et al. (2021) https://doi.org/10.1101/2021.04.20.440716 [Preprint (BioRxiv); Now published at: https://doi.org/10.1021/acsinfecdis.1c00237]
N2A

# Abolishes Mpro (SARS-CoV-2 CL3/nsp5) cleavage of ORF1a at site for mature NSP9 protein formation. 
# MacDonald et al. (2021) https://doi.org/10.1101/2021.04.20.440716 [Preprint (BioRxiv); Now published at: https://doi.org/10.1021/acsinfecdis.1c00237]
N1D

# Reduces efficiency of Mpro (SARS-CoV-2 CL3/nsp5) cleavage of ORF1a at site for mature NSP9 protein formation to 40%.
# MacDonald et al. (2021) https://doi.org/10.1101/2021.04.20.440716 [Preprint (BioRxiv); Now published at: https://doi.org/10.1021/acsinfecdis.1c00237]
N2D
